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Background: Hypertensive putaminal haemorrhage comprises major part of intra-cerebral haemorrhages, with
particularly high morbidity and mortality. However, the optimal treatments for these individuals remain controversial.
Methods: From June 2010 to August 2013, patients with hypertensive putaminal haemorrhages were treated in
the Department of Neurosurgery, West China Hospital. Information regarding the age, signs of cerebral herniation,
haematoma volume, intra-ventricular haemorrhage, intra-cerebral haemorrhage score and the treatments of each
patient were analyzed retrospectively. The outcome was evaluated by the 30-day mortality rate.
Results: The 30-day mortality rate of the patients with haematomas volume greater than or equal to 30 ml and
intra-cerebral haemorrhage scores of 1 or 2 was decreased in the surgical group compared with those in the
conservative group (1.92% VS. 21.40%, OR = 0.072, p = 0.028; 15.40% VS. 33.3%, OR = 0.365, p = 0.248, respectively). The
mortality rate of the patients with signs of cerebral herniation was not significantly different between the surgical and
conservative groups (83.30% VS. 100%; p = 0.529). The intra-cerebral haemorrhage score was significantly associated
with the 30-day mortality rate of patients with intra-cerebral haemorrhages (r = −0.798, p < 0.001).
Conclusion: Patients with basal ganglia haematomas volume greater than or equal to 30 ml and intra-cerebral
haemorrhage scores of 1 or 2 could benefit from the surgical removal of haematomas. The intra-cerebral haemorrhage
score can accurately predict the 30-day mortality rate of patients with hypertensive putaminal haemorrhages.
Keywords: Spontaneous putaminal haemorrhage, Intra-cerebral haemorrhage score, Surgical indication, Intra-cerebral
haemorrhageBackground
A spontaneous intra-cerebral haemorrhage (ICH) is a
devastating subtype of stroke with an annual incidence
of 20–30 per 1,000,000 people [1]. Haematomas within
the basal ganglia comprise 60% of all cases with hyper-
tensive ICHs, and these cases have a particularly high
morbidity and mortality despite optimized treatments
[2]. Dennis MS et al. have reported that the one-year
survival rate of patients with these haematomas is only* Correspondence: youchao1006@sina.cn
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unless otherwise stated.38% [3] and that most survivors are disabled [4]. How-
ever, the role of surgical and medical therapy in treating
putaminal haemorrhage remains controversial. Although
the Surgical Trial in Intracerebral haemorrhage (STICH)
has shown that there is no significant benefit of early
surgery compared with initial conservative treatment in
patients with spontaneous ICHs [5], trials in Japan have
shown that early surgery can improve the mortality of
patients with spontaneous ICHs [6]. Furthermore, sev-
eral recent studies have suggested that haematoma clot
reduction can limit the brain oedema and local ischae-
mia, as well as the severity of the neurological deficitsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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that a subset of patients with basal ganglia haemorrhages
could benefit from the micro-surgical evacuation of hae-
matomas. The ICH score is a simple and reliable clinical
grading scale that is used for predicting the early mortal-
ity of patients with ICHs [8]. However, there are no
existing data regarding treatment selection on the basis
of haematoma volume and the ICH score of patients with
basal ganglia haemorrhages. Therefore, we conducted a
retrospective study to investigate whether the patients
with hypertensive putaminal haemorrhages who can bene-
fit from the surgical removal of haematomas on the basis
of the haematoma volume and ICH score.
Methods
From June 2010 to August 2013, the medical records of
patients with hypertensive basal ganglia haemorrhages
who were admitted to the Department of Neurosurgery
of West China Hospital were retrospectively reviewed.Figure 1 The basal ganglia hematoma was evacuated by transsylvian
frontal-temporal craniotomy; B: The dural was opened, the sylvian was seen (ye
left basal ganglia of the head, when the patient was admission to neurosurger
was totally removed and there was no obvious parenchymal injuries.Information on their basic clinical characteristics, treat-
ments and 30-day outcomes after the ictus was collected.
The exclusion criteria were as follows: 1) patients with
haemorrhages caused by cerebral aneurysms, arterioven-
ous malformations, brain injuries, cerebral tumours or
infarctions, and patients who did not undergo computed
tomography cerebral angiography; 2) patients with dys-
functions of coagulation, liver cirrhosis, uremia, heart fail-
ure, chronic obstructive pulmonary disease or pregnancy;
3) patients on anticoagulant therapy; 4) patients with
haemorrhagic conversion after stoke.
All of the variables that were possibly associated with
the outcomes of patients with hypertensive basal ganglia
hemorraghe were evaluated. Age, signs of cerebral her-
niation (dilated and fixed pupils), haematoma volume,
intra-ventricular haemorrhage, surgical intervention and
ICH score were recorded. The haematoma volume was cal-
culated with the planimetric method (ABC/2) [9]. Further-
more, the presence of an intra-ventricular haemorrhage-transinsular approach. A: A small question mark incision line for the
llow arrow); C: The CT scan demonstrated a large hematoma within the
y department; D: postoperative CT scan showed the intracranial hematoma
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The patients received surgical haematoma removal through
the transsylvian-transinsular approach (Figure 1) or the
transcortical-transtemporal approach (Figure 2), and all of
the operations were performed within 72 h of the ictus.
The surgical team included three skilled professors, and
the surgical procedure was determined by the neurosur-
geon. If the patients with basal ganglia hematoma volume ≥
30 ml, shift of the midline ≥ 5 mm, compression of the ven-
tricle ≥ 20%, or signs of cerebral herniation, the surgical
intervention was mandatory according to the protocol
of neurosurgery department. Mortality was assessed
30 days after the ICH ictus. Comatose patients who
were discharged voluntarily by their relatives were re-
corded as deaths. Conscious patients who were dis-
charged were interviewed over telephone 30 days after the
ictus. The patients or their relatives signed informed con-
sents after a thorough explanation of the surgical or con-
servative treatments. The patients signed the informed
consent for the publication of their clinical images. The
trial was approved by the Biological and Medical Ethics
Committee of West China Hospital.Figure 2 The basal ganglia hematoma was evacuated by Transcortica
parietal-temporal craniotomy; B: The CT scan demonstrated a large hematoma
when the patient was admission to neurosurgery department; C: both of aneur
within the basal ganglia except of the intriventriclar hemorrhage, was totally remStatistical analysis
The statistical analysis was performed using SPSS 19.0
software (IBM Corporation, Armonk, NY, USA). The
categorical variables are presented as frequencies (per-
centages) and the continuous variables are presented as
means ± standard deviations(SD). For the univariate ana-
lysis, the frequencies of the parameters were compared
by Chi-square tests for categorical variables. Student’s t-
tests were used to compare the continuous variables.
The associations of the ICH scores with the 30-day mor-
tality rate of the patients with basal ganglia haemorrhages
were assessed with a binary logistic regression. P values
less than 0.05 were considered statistically significant.
Results
A total of 310 patients with putaminal haemorrhages were
enrolled in our study (Table 1). There were 129 patients in
the surgical treatment group and 181 patients in the opti-
mal conservative treatment group. The haematoma vol-
ume in the surgical group was significantly larger than
that in the conservative group (38.33 ± 18.35 VS. 24.78 ±
16.69; p < 0.001). The ICH score in the surgical group wasl-transtemporal approach. A: A horseshoe shape incision line for the
within the right basal ganglia of the head and intraventricular hemorrhage,
ysm and AVM were found on CTA; D: CT scan showed the hematoma
oved on postoperative day 2.
Table 1 Baseline clinical characteristics of 310 patients






(N = 129) (N = 181)
Age(mean ± SD) 56.59 ± 12.25 58.48 ± 12.78 0.192
Male/female 93/36 126/55 0.637
Hematoma volume
(mean ± SD)
38.33 ± 18.35 24.78 ± 16.69 <0.001
Presense of IVH(n,%) 64(35.36%) 42(32.26%) 0.608
ICH score(mean ± SD) 1.71 ± 1.26 1.20 ± 1.42 0.001
Mortality rate of 30-day 18(13.95%) 31(17.13%) 0.45
Table 3 The 30-day mortality of 157 patients with basal
ganglia hematoma (≥30 ml) based on ICH score between
surgical and conservative group
ICH
score





1 1.92% (N = 51) 21.40% (N = 24) 0.072 0.028
2 15.40% (N = 18) 33.30% (N = 9) 0.365 0.248
3 37.50% (N = 11) 22.20% (N = 17) 2.103 0.661
4 33.30% (N = 13) 54.50% (N = 11) 0.417 0.204
5 100.00% (N = 3) None
N, number of the patients.
None, no patient with an ICH score of 5 in the conservative group.
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(1.71 ± 1.26 VS. 1.20 ± 1.42; p = 0.001). The 30-day
mortality rate was not significantly different between
the surgical and conservative groups (13.95% VS. 17.13%;
p = 0.45). Only 3 patients were aged greater than or equal
to 80 years, and 157 patients (50.6%) had an initial haema-
toma volume ≥30 ml.
There were 157 patients with basal ganglia haemato-
mas volume ≥ 30 ml (Table 2). The 30-day mortality rate
of the patients with haematoma volumes of ≥ 30 ml was
significantly lower in the surgical group compared with
those in the conservative group (15.6% VS. 62.3%; p =
0.002). The 30-day mortality rate of the patients with
different ICH scores was different in the surgical group
compared with that in the conservative group (Table 3).
The 30-day mortality rate of the patients with ICH
scores of 1 was significantly decreased in the surgical
group compared to that in the conservative group
(1.92% VS. 21.40%; OR = 0.072; p = 0.028). The 30-day
mortality rate of the patients with ICH scores of 2 was
obviously decreased (15.4% VS. 33.3%; OR = 0.365; p =
0.248). However, the 30-day mortality rate of the pa-
tients with ICH scores of 3 in the surgical group was
even higher than that in the conservative group (37.50%
VS. 22.20%; OR = 2.103; p = 0.661). There were 18Table 2 Clinical characteristics of 157 patients with basal






N = 96 N = 61
Male/female 72/24 42/19 0.4
Age(mean ± SD) 56.53 ± 12.50 57.95 ± 13.58 0.504
ICH score(mean ± SD) 2.04 ± 1.21 2.67 ± 1.21 0.002
Hematoma volume
(mean ± SD)
45.13 ± 15.99 43.30 ± 15.77 0.481
Presence of IVH(n,%) 33(34.3%) 38(62.3%) 0.001
Signs of hernia (n,%) 12 (12.5%) 6(9.8%) 0.610
30-day mortality rate(n,%) 15(15.6%) 23(62.3%) 0.002patients with basal ganglia haematomas volume of ≥ 30 ml
and signs of cerebral herniation. The total 30-day mortal-
ity rate was up to 88.9%. The 30-day mortality rate in the
surgical group and conservative group was 83.3% and
100%, respectively. However, there was no significant dif-
ference between the two groups (p = 0.526).
Each increase in the ICH score was associated with an
increase in the 30-day mortality rate (Figure 3). All of
the patients with ICH scores of 0 survived, whereas none
of the patients with ICH scores of 5 survived. The 30-
day mortality rate of patients with ICH scores of 1, 2, 3
and 4 were 6.6%, 25%, 34.5% and 48.7%, respectively. A
linear regression showed that the ICH score was nega-
tively correlated with the 30-day mortality of the patients
with basal ganglia haemorrhages (r = −0.798, p < 0.001).
Discussion
Our study showed that the 30-day mortality rate of pa-
tients with moderate basal ganglia haematomas was sig-
nificantly decreased in the surgical group than that in
the conservative group, and these results were similar toFigure 3 The ICH score and 30-day mortality rate. The each
increase in the ICH score was associated with an increase in 30-day
mortality rate.
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about combining ICH score and hematoma volume as
the indication of surgical removal of hypertensive basal
ganglia hematoma. Haematoma volume is a very import-
ant factor in the surgical indication of patients with
ICHs. In our study, the total 30-day mortality rate of pa-
tients with basal ganglia haematomas of 30 ml or more
and ICH scores of 1 was significantly lower in the surgi-
cal group than in the conservative group. For the pa-
tients with ICH scores equal to 2, the 30-day mortality
rate was obviously decreased in the surgical group com-
pared with that that in the conservative group. It dem-
onstrated that haematoma clot evacuation could limit
the brain oedema and local ischaemia.
The 30-day mortality rate of patients with basal gan-
glia haematomas volume of ≥ 30 ml and signs of cerebral
herniation was up to 90% even the hematoma was evac-
uated surgically within 24 h after the ictus. In our study,
16 of 18 patients with signs of herniation died within
1 week. The possible explanation was that only removal
of haematomas might be insufficient to relieve the in-
creased intra-cranial hypertension. The intra-cranial hyper-
tension would increase again to severe values in few hours
because of swelling of brain. Furthermore, the patients
with ICH scores equal to 3, the 30-day mortality rate was
higher in the surgical group than in the conservative
group. Therefore, Treatment should be individualised
for patients with basal ganglia haemorrhages. The ICH
score was highly associated with the 30-day mortality
rate of patients with basal ganglia haemorrhages, which
was similar to other studies [14,15]. Therefore, the ICH
score would provide a standard assessment tool, which can
be determined rapidly and easily, for treatments selection
of patients with hypertensive basal ganglia haemorrhage.
This study demonstrated that surgical intervention
would decrease the 30-day mortality rate of patients with
hypertensive basal ganglia haematomas of ≥ 30 ml and
ICH scores of 1 or 2. But this retrospective study had
some limitations. The hematoma removal was through
different surgical procedures. Some patients with large
haematoma didn’t receive surgical intervention because of
economy; However, a subset of patients with basal ganglia
hematoma volume of < 30 ml and shift of midline ≥ 5 mm
received surgical removal of hematoma. A more definitive
conclusion will be achieved from the future trial.
Conclusion
Patients with basal ganglia haematomas volume ≥ 30 ml
and ICH scores of 1 or 2 could benefit from micro-
surgical interventions. ICH scores should be assessed as
part of the surgical indications and routine clinical care.
Abbreviation
ICH score: Intracerebral hemorrhage score.Competing interests
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